A team of scientists from the University of Michigan Rogel Cancer Center has developed the first drug-like compounds to inhibit a key family of enzymes whose malfunction is associated with several types of cancer, including an aggressive form of childhood leukemia.
Click here for original story, Scientists develop first drug-like compounds to inhibit elusive cancer-linked enzymes
Source: Phys.org